Christopher Liptrot

Christopher Liptrot has extensive work experience in finance and accounting. Their most recent position was Vice President Finance at Laborie since May 2023. Prior to that, they served as the U.S. Controller at Amryt Pharma plc from October 2020 to May 2023. Christopher also worked at Anika Therapeutics, where they initially served as the Assistant Controller from April 2017 to January 2019, and later took on the role of Director of Finance from February 2019 to October 2020. Before joining Anika Therapeutics, they held positions at CFGI as a Senior Manager from January 2017 to April 2017, and as a Manager from January 2016 to April 2017. Their earliest work experience was as an Audit Manager at Deloitte from September 2009 to January 2016.

Christopher Liptrot earned a Bachelor of Science degree in Corporate Finance & Accounting from Bentley University, completing their education from 2005 to 2009. Christopher further pursued a Masters degree in Accounting from Boston College Carroll School of Management during 2009-2010. In 2012, they obtained a Certified Public Accountant certification from the Connecticut Department of Energy and Environmental Protection, followed by a certification from the State of Massachusetts in 2013.